Dhampur Bio Organics Limited (BOM:543593)
India · Delayed Price · Currency is INR 111.20
-1.35 (-1.20%)
At close: Jun 3, 2026
Dhampur Bio Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 31,334 | 18,615 | 18,644 | 24,075 | 15,641 |
Other Revenue | 318.3 | - | - | - | - |
| 31,652 | 18,615 | 18,644 | 24,075 | 15,641 | |
Revenue Growth (YoY) | 70.03% | -0.16% | -22.56% | 53.92% | - |
Cost of Revenue | 26,225 | 14,218 | 14,027 | 18,580 | 11,718 |
Gross Profit | 5,427 | 4,398 | 4,617 | 5,495 | 3,923 |
Selling, General & Admin | 1,134 | 1,042 | 1,005 | 1,109 | 750.5 |
Other Operating Expenses | 2,666 | 1,990 | 2,184 | 2,221 | 1,261 |
Operating Expenses | 4,389 | 3,570 | 3,684 | 3,735 | 2,324 |
Operating Income | 1,039 | 827.2 | 933.1 | 1,760 | 1,599 |
Interest Expense | -629.8 | -645.5 | -433.6 | -380.8 | -294.2 |
Interest & Investment Income | - | 15.9 | 23.1 | 4.8 | 5.2 |
Currency Exchange Gain (Loss) | - | -0.6 | 14.1 | -7.2 | -0.1 |
Other Non Operating Income (Expenses) | - | -25.5 | -19.7 | -27.6 | -2.7 |
EBT Excluding Unusual Items | 409 | 171.5 | 517 | 1,349 | 1,307 |
Merger & Restructuring Charges | - | - | - | -2 | -30 |
Gain (Loss) on Sale of Assets | - | 3.2 | 137.9 | 0.3 | 16.7 |
Other Unusual Items | - | -17.6 | - | - | - |
Pretax Income | 409 | 157.1 | 654.9 | 1,348 | 1,294 |
Income Tax Expense | 157.2 | 10.2 | 190 | 236.7 | 270.8 |
Net Income | 251.8 | 146.9 | 464.9 | 1,111 | 1,023 |
Net Income to Common | 251.8 | 146.9 | 464.9 | 1,111 | 1,023 |
Net Income Growth | 71.41% | -68.40% | -58.16% | 8.57% | - |
Shares Outstanding (Basic) | 66 | 66 | 66 | 66 | 66 |
Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 66 |
Shares Change (YoY) | -0.19% | - | - | - | - |
EPS (Basic) | 3.81 | 2.21 | 7.00 | 16.74 | 15.41 |
EPS (Diluted) | 3.80 | 2.21 | 7.00 | 16.74 | 15.41 |
EPS Growth | 71.73% | -68.40% | -58.16% | 8.57% | - |
Free Cash Flow | 1,755 | -161.7 | -2,720 | 1,448 | -4,078 |
Free Cash Flow Per Share | 26.49 | -2.44 | -40.98 | 21.81 | -61.43 |
Dividend Per Share | - | 1.250 | 2.500 | 3.500 | - |
Dividend Growth | - | -50.00% | -28.57% | - | - |
Gross Margin | 17.15% | 23.62% | 24.76% | 22.82% | 25.08% |
Operating Margin | 3.28% | 4.44% | 5.00% | 7.31% | 10.22% |
Profit Margin | 0.80% | 0.79% | 2.49% | 4.61% | 6.54% |
Free Cash Flow Margin | 5.54% | -0.87% | -14.59% | 6.01% | -26.07% |
EBITDA | 1,627 | 1,326 | 1,388 | 2,133 | 1,889 |
EBITDA Margin | 5.14% | 7.12% | 7.45% | 8.86% | 12.07% |
D&A For EBITDA | 588.1 | 498.8 | 455.1 | 373.2 | 289.5 |
EBIT | 1,039 | 827.2 | 933.1 | 1,760 | 1,599 |
EBIT Margin | 3.28% | 4.44% | 5.00% | 7.31% | 10.22% |
Effective Tax Rate | 38.44% | 6.49% | 29.01% | 17.56% | 20.93% |
Revenue as Reported | 31,652 | 26,966 | 24,183 | 26,659 | 15,718 |